MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

Similar documents
Current and Future Imaging Trends in Risk Stratification for CAD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

CVD risk assessment using risk scores in primary and secondary prevention

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

CARDIOMETABOLIC SYNDROME

Cardiac Screening with Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging

Diagnostic and Prognostic Value of Coronary Ca Score

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017

Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Learn and Live SM. ACCF/AHA Pocket Guideline

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Calcium scoring Clinical and prognostic value

New Paradigms in Predicting CVD Risk

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Which CVS risk reduction strategy fits better to carotid US findings?

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram

Lipid Management 2013 Statin Benefit Groups

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics

How to Reduce Residual Risk in Primary Prevention

How would you manage Ms. Gold

Khurram Nasir, MD MPH

CLINICAL OUTCOME Vs SURROGATE MARKER

Cardiac CT Angiography

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Landmesser U et al. Eur Heart J 2017; /eurheartj/ehx549

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Review of guidelines for management of dyslipidemia in diabetic patients

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Atherosclerotic Disease Risk Score

Cardiovascular risk assessment in patients with diabetes

Prevention of Heart Disease: The New Guidelines

Placebo-Controlled Statin Trials

1. Which one of the following patients does not need to be screened for hyperlipidemia:

2013 Lipid Guidelines Practical Approach. Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS

Heart Disease in Women: Diagnostic Approaches and Management

Medical Policy. Medical Policy. MP Computed Tomography to Detect Coronary Artery Calcification

Biomarkers in Cardiovascular Diseases. Peter Ganz, MD. Chief, Division of Cardiology, San Francisco General Hospital

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

Intima-Media Thickness

Lipid Panel Management Refresher Course for the Family Physician

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

New Guidelines in Dyslipidemia Management

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

Weintraub, W et al NEJM March Khot, UN et al, JAMA 2003

The Art of Cardiovascular Risk Assessment

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

BENEFIT APPLICATION BLUECARD/NATIONAL ACCOUNT ISSUES

Coronary Artery Calcification

Assessing atherosclerotic risk for long term preventive treatment

Cardiovascular Risk Assessment: A Systematic Review of Guidelines.

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

Is computed tomography angiography really useful in. of coronary artery disease?

Treatment to reduce cardiovascular risk: multifactorial management

Diabetes and Heart Disease

Learning Objectives. Predicting and Preventing Cardiovascular Disease. ACC/AHA Cholesterol Guidelines Key differences vs ATP III

Preventing Cardiovascular Disease With Lipid Management: Matching Therapy to Risk

Vascular calcification in patients with Diabetes Mellitus. Dr Jamie Bellinge University of Western Australia Royal Perth Hospital

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

Disclosures. Prevention of Heart Disease: The New Guidelines. Summary of Talk. Four guidelines. No relevant disclosures.

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Cho et al., 2009 Journal of Cardiology (2009), 54:

Lipid Management C. Samuel Ledford, MD Interventional Cardiology Chattanooga Heart Institute

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

Quality Payment Program: Cardiology Specialty Measure Set

No relevant financial relationships

Beyond Framingham: Risk Assessment & Treatment for Primary Prevention

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None

Diabetes Mellitus: A Cardiovascular Disease

ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS

Testing the Asymptomatic CAD Patient: When and Why?

Latest Guidelines for Lipid Management

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006

CORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT ASHLEIGH A. OWEN, MD

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

CVD risk estimation in populations with high prevalence of MetS. Dilek Ural, 12 March 2017 Koç University, Istanbul

Carotid Ddisease, Carotid IMT and Risk of Stroke

Sanger Heart & Vascular Institute Symposium 2015

surtout qui n est PAS à risque?

New Guidelines in Dyslipidemia Management

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

When Should I Order a Stress Test or an Echocardiogram

2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.

Transcription:

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

DEFINITION OF A SCREENING TEST TESTING FOR A DISEASE OR CONDITION IN ASYMPTOMATIC PERSONS TO IDENTIFY THE CONDITION BEFORE IT MANIFESTS CLINICALLY

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

REQUIREMENTS OF A GOOD SCREENING TEST The prevalence of the disease must be high enough to justify screening The test must accurately diagnose the disease and characterise low and high risk patients The test must have incremental value beyond other standard measures of risk Identification of afflicted individuals should lead to a treatment that improves outcomes The screening test should be easily available and free of risk The screening test should be cost effective

PREVALENCE OF DIABETES IN THE USA 1980 2011 (millions) CDC, National Institute for Statistics, USA.Gov

AGE SPECIFIC SURVIVAL AMONG PATIENTS WITH TYPE 1 DIABETES COMPARED WITH THE GENERAL POPULATION Livingstone et al, JAMA 2015;313(1):37-44

CAUSE SPECIFIC CONTRIBUTION TO MORTALITY BY AGE AND SEX Livingstone et al, JAMA 2015;313(1):37-44

CHANGES IN DIABETIC RELATED COMPLICATIONS, 1990-2010 Gregg et al, NEJM 2014;370:1515-23

DIABETES MELLITUS IS A CORONARY ARTERY DISEASE EQUIVALENT Haffner et al, NEJM1998;339:229-34

EVENT RATES FOR CARDIOVASCULAR MORTALITY IN MEN (A) AND WOMEN (B) STRATIFIED BY AGE AND SEX IN RELATION TO DIABETES MELLITUS AND PRIOR MI Schramm TK et al, Circulation 2008;117:1945-54

CARDIOVASCULAR RISK PREDICTION SCORES Framingham CHD score 1998 Framingham CVD score 2001 UKPDS risk engine 2001 ATP III modified Framingham score 2002 Reynolds score 2007 AHA-ACC ASCVD score 2013

CARDIOVASCULAR RISK FACTORS DIABETES OBESITY RACE SEX LDL BLOOD PRESSURE EXERCISE FAMILY HISTORY AGE HS-CRP HOMOCYSTEINE SMOKING

FRAMINGHAM RISK SCORE LOW MEDI UM HIGH 0% 100% 10 20 10 Year risk of a cardiovascular event

PERCENTAGE DISCORDANCE BETWEEN PREDICTED AND OBSERVED CARDIOVASCULAR EVENTS USING 5 RISK PREDICTION ALGORITHMS Ridker PM, Annals Int Med 2015;162:313-14

THE MAJORITY OF ADVERSE EVENTS OCCUR IN THE LOW RISK POPULATION Rose G. BMJ 1981;282:1847-51

SCREENING TESTS FOR CORONARY ATHEROSCLEROSIS ECG Stress ECG Stress echocardiography Carotid intima media thickness (IMT) Myocardial perfusion imaging CT coronary artery calcium (CAC) CT coronary angiography (CTCA)

MYOCARDIAL PERFUSION IMAGING

PREDICTION OF CARDIOVASCULER EVENTS USING MPI IN ASYMPTOMATIC PATIENTS WITH DIABETES AUTHOR YEAR N AGE RISK RATIO Torremocha 2001 72 55 2.7 Le Feuvre 2005 100 61 0.8 Sejil 2006 203 54 3.7 Sholte 2009 120 53 10 Choi 2009 116 62 1.9 Jaqueminet 2010 204 65 n/a Giovachini 2013 77 63 2.8 De Lorenzo 2002 180 61 2.4 Yamasaki 2010 485 67 1.9

ÇT CORONARY ARTERY CALCIUM

SURVIVAL STRATIFIED BY CAC SCORE Raggi P et al, JACC 2004;43:1663-9

CUMULATIVE RELATIVE RISK RATIO FOR EVENTS IN NO CAC VERSUS CAC IN ASYMPTOMATIC PATIENTS Sarwar et al, JACC Imaging 2009;2:675-88

CAC IN ASYMPTOMATIC DIABETIC PATIENTS Hecht HS et al, Journal of Diabetes 2012;4:342-50

WHY WERE THE DIAD AND FACTOR 64 TRIALS NEGATIVE? The event rate in the control arms were extremely low resulting in the trials being underpowered Mean entry LDL in control arm 2.3mmol/L Mean systolic BP 130mmHg Inability to implement a more aggressive strategy in patients with an abnormal CCTA The assumption regarding the benefits of CCTA may have been overly optimistic

WHAT IS THE TAKE HOME MESSAGE? Further RCT are needed which focus on intermediate and high risk patients Guideline based therapy for cholesterol and blood pressure should be implemented more consistently Until further data become available, widespread MPI or CCTA cannot be recommended for asymptomatic patients with diabetes. THANK YOU

Preis et al, Circulation 2009;120:212-20

EVENT RATES FOR THE COMPOSITE END POINT OF MI, STRKE AND CARDIOVASCULAR DEATH IN MEN (A) AND WOMEN (B) STRATIFIED BY AGE AND SEX IN RELATION TO DIABETES MELLITUS AND PRIOR MI Schramm TK et al, Circulation 2008;117:1945-54

TRENDS FOR MEDICAL TREATMENT DURING FOLLOW- UP IN RELATION TO DIABETES AND PRIOR MI

AHA-ACC ASCVD 7.5% LOW ME DI UM HIGH 0% 100% 5 10 Risk of a cardiovascular event

CHARACTERISTICS AND RISK RATIO FOR CAC IN ASYMPTOMATIC PATIENTS Hecht HS et al, Journal of Diabetes 2012;4:342-50

ANNUAL EVENT RATES IN PRIMARY PREVENTION PATIENTS AT VARYING CAC LEVELS

RECLASSIFICATION OF FRS WITH CAC IN PRIMARY PREVENTION STUDIES